M N Blinov - JoVE Visualize

Showing results (51-60 of 63) with videos related to

Pageof 7

Sort By:

Annals of Hematology|March 23, 2001

HLA-DR4-Ala74 beta is associated with risk and poor outcome of severe aplastic anemiaS I Kapustin, T I Popova, A A Lyshchov, et al.

Voprosy Onkologii|October 26, 1999

[Diagnostic and prognostic significance of blood-serum ceruloplasmin, acetylcholinesterase and total proteolytic activity in patients with multiple myeloma]S S Bessmel'tsev, L P Rybakova, N L Gritskevich, et al.

Terapevticheskii Arkhiv|January 1, 1997

[The importance of studies of the glycosaminoglycans in the peripheral blood leukocytes of patients in the diagnosis of the phases of chronic myeloleukemia]M F Kharchenko, S S Bessmel'tsev, O A Rukavitsyn, et al.

Eksperimental'Naia Onkologiia|January 1, 1990

[Ultrastructural organization of nucleoli and ribosome level in lymphocytes at different stages of maturation in patients with chronic B-cell lymphocytic leukemia]E O Morozova, T S Blinova, A S Tsveĭbakh, et al.

Voprosy Onkologii|February 24, 2001

[Diagnostic and prognostic significance of some laboratory indices of cerebrospinal fluid in multiple myeloma]S S Bessmel'tsev, I F Lubo-Lesnichenko, K M Abdulkadyrov, et al.

Voprosy Onkologii|October 23, 2003

[Anticytosine therapy for primary myelodysplastic syndrome]K M Abdulkadyrov, S V Gritsaev, S S Bessmel'tsev, et al.

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|January 1, 1993

[The prognostic role of determining spontaneous leukocyte DNA damage and that occurring during chemotherapy in leukemia patients]E O Morozova, Zh Iu Sidorova, M N Blinov, et al.

Terapevticheskii Arkhiv|January 1, 1996

[Is the cytogenetic verification of chronic myeloleukemia always obligatory?]K M Abdulkadyrov, O A Rukavitsyn, S S Bessmel'tsev, et al.

Terapevticheskii Arkhiv|January 1, 1995

[Experience with the use of reaferon (alfa 2-interferon) for treating patients with chronic myeloleukemia]K M Abdulkadyrov, S I Moiseev, E G Shcherbakova, et al.

Terapevticheskii Arkhiv|December 13, 2003

[Genetic determinants of hereditary thrombophilia in pathogenesis of venous thrombosis]S I Kapustin, M N Blinov, V D Kargin, et al.

Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:

Pageof 7

Annals of Hematology|March 23, 2001

HLA-DR4-Ala74 beta is associated with risk and poor outcome of severe aplastic anemiaS I Kapustin, T I Popova, A A Lyshchov, et al.

Voprosy Onkologii|October 26, 1999

[Diagnostic and prognostic significance of blood-serum ceruloplasmin, acetylcholinesterase and total proteolytic activity in patients with multiple myeloma]S S Bessmel'tsev, L P Rybakova, N L Gritskevich, et al.

Terapevticheskii Arkhiv|January 1, 1997

[The importance of studies of the glycosaminoglycans in the peripheral blood leukocytes of patients in the diagnosis of the phases of chronic myeloleukemia]M F Kharchenko, S S Bessmel'tsev, O A Rukavitsyn, et al.

Eksperimental'Naia Onkologiia|January 1, 1990

[Ultrastructural organization of nucleoli and ribosome level in lymphocytes at different stages of maturation in patients with chronic B-cell lymphocytic leukemia]E O Morozova, T S Blinova, A S Tsveĭbakh, et al.

Voprosy Onkologii|February 24, 2001

[Diagnostic and prognostic significance of some laboratory indices of cerebrospinal fluid in multiple myeloma]S S Bessmel'tsev, I F Lubo-Lesnichenko, K M Abdulkadyrov, et al.

Voprosy Onkologii|October 23, 2003

[Anticytosine therapy for primary myelodysplastic syndrome]K M Abdulkadyrov, S V Gritsaev, S S Bessmel'tsev, et al.

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|January 1, 1993

[The prognostic role of determining spontaneous leukocyte DNA damage and that occurring during chemotherapy in leukemia patients]E O Morozova, Zh Iu Sidorova, M N Blinov, et al.

Terapevticheskii Arkhiv|January 1, 1996

[Is the cytogenetic verification of chronic myeloleukemia always obligatory?]K M Abdulkadyrov, O A Rukavitsyn, S S Bessmel'tsev, et al.

Terapevticheskii Arkhiv|January 1, 1995

[Experience with the use of reaferon (alfa 2-interferon) for treating patients with chronic myeloleukemia]K M Abdulkadyrov, S I Moiseev, E G Shcherbakova, et al.

Terapevticheskii Arkhiv|December 13, 2003

[Genetic determinants of hereditary thrombophilia in pathogenesis of venous thrombosis]S I Kapustin, M N Blinov, V D Kargin, et al.

Pageof 7